What we, other provinces and territories and any health ministers I'm speaking to at that level, are looking at is, the sooner we can catch it and know what we can put in place in the way of screening and detection, the better the outcomes. What can we put in place? What technologies are coming? What AI-supported initiatives can we put in place to make that initial detection as early as possible for any of our cancer people, whether it's colorectal, breast or any of your FIT tests? There's early detection now with lungs.
We're also now looking at a new test. It will be a liquid biopsy, a blood test that's coming. We're currently waiting on the FDA to approve that. The independent advisory committee to the FDA has suggested that the FDA approve that, and it will be that initial screening for about 50 different types of cancer. That's being watched very closely. It is available in some of the provinces now through private clinics and through insurance companies. A lot of them are paying for it now. The push is towards the concept that, the earlier we detect it, the better the outcomes, the less impact on the patient and the less impact on the system.
Through our research, we know there's a financial toxicity to any kind of cancer diagnosis. We're looking at how we decrease that, particularly for women in the breast cancer space under the age of 55 who are financially impacted quite significantly with a breast cancer diagnosis. The earlier we can catch it, the better the outcomes for the patient, the less financial toxicity and the better for the system overall. That's what we're looking at.